MRI Screening in Men at High Risk of Developing Prostate Cancer
https://www.facingourrisk.org/research-clinical-trials/study/260/screening-in-men-at-high-risk-of-developing-prostate-cancer
Clinicaltrials.gov identifier:
NCT05608694 (https://clinicaltrials.gov/show/NCT05608694)
Prevention
Screening using MRI for men at risk of developing prostate cancer
Study Contact Information:
Please contact Contact: Scott Eggener, MD (773) 702-1001 [email protected] or
Mitchell Oddo (773) 834-8771 [email protected]
About the Study
This study will place participants into one of four groups:
- Group 1: Men with inherited mutations in the following genes: ATM, BRCA1, BRCA2, CHEK2, EPCAM, HOXB13, MLH1, MSH2, MSH6, PALB2 and PMS2
- Group 2: Men who have a high risk of prostate cancer based on their genetic risk score (GRS)
- Group 3: Men with a family history of prostate cancer in at least one sibling, father, uncle, or grandfather
- Group 4: Men at low risk of prostate cancer
All groups will receive the same prostate MRIs.
What the Study Involves
Participants will have a prostate MRI every three years for 15 years or until prostate cancer is found.
Study Sites
Illinois
Chicago
University of Chicago
Contact: Scott Eggener, MD (773) 702-1001 [email protected]
Contact: Mitchell Oddo (773) 834-8771 [email protected]
This Study is Open To:
Men 18 years and older who:
- Have not had prostate cancer
- Have not had prostate surgery
This Study is Not Open To:
Men who do not meet the inclusion criteria defined above and those who:
- Cannot have an MRI
- Do not have a rectum
- Have had a hip replacement
- Have had a prostate biopsy or MRI within the last three years
About FORCE
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.